Health-related quality of life (HRQoL) with tepotinib in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the phase II VISION trial Meeting Abstract
| Authors: | Gasking, S.; Reinmuth, N.; Mazieres, J.; Popat, S.; Paz-Ares, L.; Hook, E.; Hatswell, A.; Vlassak, S.; Johne, A.; Vioix, H.; Paik, P. |
| Abstract Title: | Health-related quality of life (HRQoL) with tepotinib in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the phase II VISION trial |
| Meeting Title: | 51st Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 20 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Nov 13-15 |
| Meeting Location: | Gold Coast, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2024-11-01 |
| Start Page: | 132 |
| End Page: | 133 |
| Language: | English |
| ACCESSION: | WOS:001352150600176 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.14117 |
| Notes: | Meeting Abstract: 243 -- This meeting abstract was published under the "Poster Abstracts" section of the issue -- Source: Wos |
